SCHEMBL241799

SCHEMBL241799

OCCc1cc[c]cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8146100 0.85 CA2 (0.50)
SCHEMBL242199 0.84 CA2 (0.45)
SCHEMBL158758 0.82 CA2 (0.47)
SCHEMBL6576818 0.82 GFER (0.40)
SCHEMBL7167586 0.80 CA2 (0.48)
SCHEMBL3585945 0.80 CA2 (0.48)
Phenylethyl Alcohol SCHEMBL908803 0.80 TDP1 (0.73)
SCHEMBL5792380 0.80 CA2 (0.45)
Ammonia Solution, Strong SCHEMBL28350189 0.79 CA2 (0.47)
SCHEMBL40656 0.78 CA2 (0.77)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1086 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116199667-B Halogen substituted isoindoline compound and application thereof 成都分迪药业有限公司 2024-05-03 CN claimed
WO-2023207241-A1 HALOGEN-SUBSTITUTED ISOINDOLINE COMPOUND AND USE THEREOF 成都分迪药业有限公司 2023-11-02 WO claimed
CN-116554243-A Novel glycoside compound found from gastrodia elata and preparation thereof 贵州大学 2023-08-08 CN claimed
EP-4188075-A1 NUTRIENT LOSS REDUCTION METHOD, USES AND PRODUCTS PGG Wrightson Seeds Limited (NZ) 2023-06-07 EP claimed
CN-116234546-A GPX4 inhibitors, pharmaceutical compositions thereof and their use in the treatment of GPX4 mediated diseases 嘉兴优博生物技术有限公司 2023-06-06 CN claimed
CN-116199667-A Halogen substituted isoindoline compound and application thereof 成都分迪药业有限公司 2023-06-02 CN claimed
EP-3988100-A1 ADENOSINE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR STEREOISOMERIDE THEREOF, AND USE Academy Of Military Medical Sciences (CN) 2022-04-27 EP claimed
CN-114025763-A Adenosine compound, pharmaceutically acceptable salt or stereoisomer thereof and application 中国人民解放军军事科学院军事医学研究院 2022-02-08 CN claimed
WO-2022025774-A1 NUTRIENT LOSS REDUCTION METHOD, USES AND PRODUCTS PGG WRIGHTSON SEEDS LIMITED (NZ) 2022-02-03 WO claimed
WO-2021183702-A1 GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING GPX4-MEDIATED DISEASES EUBULUS BIOTHERAPEUTICS INC. (CN) 2021-09-16 WO claimed
EP-0363223-A2 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use Sankyo Company Limited (JP) 1990-04-11 EP claimed
EP-0125311-B1 POLYESTERS CONTAINING COPOLYMERIZED, ANTHRAQUINONE COLORANT COMPOUNDS CONTAINING SULFONAMIDO GROUPS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1988-01-20 EP claimed
US-4716168-A STIMULANTS OF IMMUNE RESPONSE NORWICH EATON PHARMACEUTICALS, INC. (US) 1987-12-29 US claimed
EP-0187705-A2 Imidazo(4,5-f)quinolines useful as immunomodulating agents Norwich Eaton Pharmaceuticals, Inc. (US) 1986-07-16 EP claimed
EP-0125311-A1 POLYESTERS CONTAINING COPOLYMERIZED, ANTHRAQUINONE COLORANT COMPOUNDS CONTAINING SULFONAMIDO GROUPS. EASTMAN KODAK CO (US) 1984-11-21 EP claimed
WO-1984002136-A2 POLYESTERS CONTAINING COPOLYMERIZED, ANTHRAQUINONE COLORANT COMPOUNDS CONTAINING SULFONAMIDO GROUPS EASTMAN KODAK CO (US) 1984-06-07 WO claimed
US-4432899-A Preparing concentrated azo dye solutions using nitrite salt as both coupling component and diazotizing agent BAYER AKTIENGESELLSCHAFT (DE) 1984-02-21 US claimed
US-4403092-A COLORFAST FOOD CONTAINERS EASTMAN KODAK COMPANY (US) 1983-09-06 US claimed
US-4233214-A FOR POLYACRYLONITRILE AND ACID-MODIFIED POLYESTERS OR POLYAMIDES BAYER AKTIENGESELLSCHAFT (DE) 1980-11-11 US claimed
US-4036826-A Cationic azo dyestuffs with a hydroxyalkylated ammonium group BAYER AKTIENGESELLSCHAFT (DT) 1977-07-19 US claimed